Skip to main content
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)Diagnostics and screeningDevice

What this study is

The goal of this study is to use our Thermoacoustic Enhanced Ultrasound device to measure the fat levels in your liver and compare it to the the gold standard MRI PDFF measurements. Participants will have a scan with our device, then they will go have an abdominal MRI completed. The goal is to create a more accessible device to measure liver fat as it is an indicator for overall health and metabolic diseases.

What's being tested

  • Thermoacoustic Enhanced Ultrasound

    Intervention · DEVICE

    a novel Thermoacoustic Enhanced imaging device

Study details

Official title
Thermoacoustic Method for Estimating Liver Fat Fraction - Pilot Study I
Sponsor
Endra Lifesciences
Conditions
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis) · Fatty Liver Disease, Nonalcoholic
Enrolling
49 people
Starts
2025-08-15
Est. completion
2025-12-31
Record
View on ClinicalTrials.gov ↗